Christine D Berg

发表

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33

Wei Zheng, Peter Kraft, Vittorio Krogh, 2010, Nature Genetics.

Selection criteria for lung-cancer screening.

Timothy R Church, Hormuzd A Katki, C. Berg, 2013, The New England journal of medicine.

Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status

Peter Kraft, Sara Lindström, I-Min Lee, 2012, Journal of Medical Genetics.

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Peter Kraft, Salvatore Panico, Mattias Johansson, 2011, Journal of the National Cancer Institute.

Cancer screening: the journey from epidemiology to policy.

Diana B Petitti, Melinda C Aldrich, Robert A Hiatt, 2012, Annals of epidemiology.

Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.

Mark Robson, C. Berg, M. Robson, 2009, Journal of the National Cancer Institute.

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort

Robert N Hoover, James V Lacey, P. Prorok, 2009, BMC Cancer.

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

Paolo Vineis, Salvatore Panico, Vittorio Krogh, 2011, Nature Genetics.

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.

Peter Kraft, Sara Lindström, I-Min Lee, 2014, Human molecular genetics.

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.

Stephanie Lamart, Stephen F Kry, Marilyn Stovall, 2011, The Lancet. Oncology.

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

David A Lynch, John K Gohagan, Carl R Fuhrman, 2010, Journal of the National Cancer Institute.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Mark P Purdue, Barnett S Kramer, John K Gohagan, 2012, The New England journal of medicine.

Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

Sudhir Srivastava, Steven J Skates, Mark D Thornquist, 2011, Cancer Prevention Research.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Patrick Neven, Peter Kraft, Nazneen Rahman, 2015 .

Screening for lung cancer with low-dose computed tomography: a review of current status.

C. Berg, K. Fong, I. Yang, 2013, Journal of thoracic disease.

Karen M Kuntz, Ann G Zauber, Iris Lansdorp-Vogelaar, 2011, AJR. American journal of roentgenology.

Mortality results from a randomized prostate-cancer screening trial.

David Chia, Timothy R Church, Barnett S Kramer, 2009, The New England journal of medicine.

Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol

C Daniel Mullins, Mark Pankuch, L Christine Fang, 2019, BMJ Open.

Genome-wide association studies identify four ER negative–specific breast cancer risk loci

Patrick Neven, Michael Jones, Wei Lu, 2013, Nature Genetics.

Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk

Kwang Pyo Kim, K. P. Kim, C. Berg, 2008, Journal of medical screening.

Detectable clonal mosaicism and its relationship to aging and cancer

William Wheeler, Nan Hu, Peter Kraft, 2012, Nature Genetics.

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

Jane E. Carpenter, Peter Kraft, Gary K. Chen, 2011, Nature Genetics.

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.

William Wheeler, Hideo Tanaka, Jianxin Shi, 2014, Human molecular genetics.

The decrease in breast-cancer incidence in 2003 in the United States.

Eric J Feuer, Kathleen A Cronin, Nadia Howlader, 2007, The New England journal of medicine.

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Stephanie A Kovalchik, Hormuzd A Katki, C. Berg, 2016, JAMA.

Data sharing in clinical trials: An experience with two large cancer screening trials

Thomas M. Riley, P. Prorok, J. Rathmell, 2017, PLoS medicine.

Methods for etiologic and early marker investigations in the PLCO trial.

Robert N Hoover, Ulrike Peters, Paul Pinsky, 2005, Mutation research.

Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities.

Adeyinka O Laiyemo, P. Prorok, Chyke A Doubeni, 2010, Journal of the National Cancer Institute.

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Peter Kraft, Vittorio Krogh, Tyler J VanderWeele, 2014, American journal of epidemiology.

Potential role of HE4 in multimodal screening for epithelial ovarian cancer.

Charles W Drescher, Garnet L Anderson, Nicole Urban, 2011, Journal of the National Cancer Institute.

Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?

C. Berg, P. Pinsky, Christine D Berg, 2012, Journal of medical screening.